This is an investigational study of two new drugs being tested to treat hepatitis C genotypes 1 through 6 in people who had received a liver transplant or kidney transplant (post-transplant liver or kidney).
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)
To read the entire clinical trial description, click here…
The study is evaluating the dose of sofosbuvir plus ribavirin in adolescent patients—aged 12 to 17 yo—infected with HCV genotype 2 and 3. Once the dose is determined the same adolescent patients will be treated with the combination of sofosbuvir plus ribavirin.
Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
To view the entire clinical trial description, click here